(19)
(11) EP 2 086 540 B8

(12) CORRECTED EUROPEAN PATENT SPECIFICATION
Note: Bibliography reflects the latest situation

(15) Correction information:
Corrected version no 1 (W1 B1)

(48) Corrigendum issued on:
02.03.2011 Bulletin 2011/09

(45) Mention of the grant of the patent:
19.01.2011 Bulletin 2011/03

(21) Application number: 07857236.9

(22) Date of filing: 30.11.2007
(51) International Patent Classification (IPC): 
A61K 31/437(2006.01)
A61P 29/00(2006.01)
 C07D 471/04(2006.01)
(86) International application number:
PCT/EP2007/063106
(87) International publication number:
WO 2008/065198 (05.06.2008 Gazette 2008/23)

(54)

TRIAZOLOPYRIDINE COMPOUNDS USEFUL FOR THE TREATMENT OF DEGENERATIVE & INFLAMMATORY DISEASES

TRIAZOLOPYRIDINVERBINDUNGEN ZUR BEHANDLUNG VON DEGENERATIONS- UND ENTZÜNDUNGSKRANKHEITEN

COMPOSÉS DE TRIAZOLOPYRIDINE POUR LE TRAITEMENT DE MALADIES DÉGÉNÉRATIVES ET INFLAMMATOIRES

(84) Designated Contracting States:
AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IS IT LI LT LU LV MC MT NL PL PT RO SE SI SK TR

(30) Priority: 01.12.2006 US 868144 P

(43) Date of publication of application:
12.08.2009 Bulletin 2009/33

(73) Proprietor: Galapagos N.V.
2800 Mechelen (BE)

(72) Inventors:
  • BURRITT, Andrew
    San Marcos, CA 92078 (US)
  • EDWARDS, Paul John
    Laval, Québec H7S 2G5 (CA)
  • SCHMIDT, Wolfgang
    Saffron Walden Essex CB10 1XL (GB)
  • BIRAULT, Veronique
    Hertford Hertfordshire SG14 3JE (GB)
  • KROLL, Friedrich Erich Karl
    2800 Mechelen (BE)
  • TAO, Xueliang
    San Diego, California 92130 (US)
  • ANDREWS, Martin James Inglis
    2800 Mechelen (BE)
  • MARTINA, Sébastien Laurent Xavier
    2800 Mechelen (BE)

(74) Representative: Nichol, Maria Zenarosa et al
Galapagos NV Chesterford Research Park
Saffron Walden, Essex CB10 1XL
Saffron Walden, Essex CB10 1XL (GB)


(56) References cited: : 
WO-A-01/17999
WO-A-2005/070927
US-A1- 2006 106 023
 WO-A-2004/014908
WO-A-2006/004702
   
       
    Note: Within nine months from the publication of the mention of the grant of the European patent, any person may give notice to the European Patent Office of opposition to the European patent granted. Notice of opposition shall be filed in a written reasoned statement. It shall not be deemed to have been filed until the opposition fee has been paid. (Art. 99(1) European Patent Convention).